Case series of intravenous thrombolysis for acute ischemic stroke in confirmed COVID-19 patients: single-centre experience
- PMID: 35035211
- PMCID: PMC8743695
- DOI: 10.1186/s41983-021-00434-w
Case series of intravenous thrombolysis for acute ischemic stroke in confirmed COVID-19 patients: single-centre experience
Abstract
Background: Coronavirus disease 2019 (COVID-19) not only caused a large surge of respiratory infections, it also had a potential association with and increases the risk of stroke. The pandemic has certainly provided new challenges and opportunities in the management of acute ischemic stroke (AIS); however, data regarding outcomes of intravenous tissue plasminogen activator (IV TPA) administration in stroke patients with COVID-19 remains limited.
Case presentation: Three AIS patients with confirmed COVID-19 treated using IV tPA. One case had excellent outcome, while the other cases showed unfavorable results. The risk-benefit ratio of IV TPA in COVID-19 remains unclear.
Conclusion: In this article, we discuss the possible explanation behind these different outcomes. Although IV tPA could not cure COVID-19, we suggest that its administration should not be delayed in AIS patients with COVID-19.
Keywords: COVID-19; Case series; Intravenous thrombolysis; Ischemic stroke; Rt-PA.
© The Author(s) 2022.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures



Similar articles
-
A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients.Neurol Sci. 2020 Sep;41(9):2325-2329. doi: 10.1007/s10072-020-04591-3. Epub 2020 Jul 12. Neurol Sci. 2020. PMID: 32656711 Free PMC article.
-
Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.Stroke. 2017 Aug;48(8):2282-2284. doi: 10.1161/STROKEAHA.117.018119. Epub 2017 Jul 5. Stroke. 2017. PMID: 28679847 Free PMC article.
-
Analysis of influencing factors of early neurological improvement after intravenous rt-PA thrombolysis in acute anterior circulation ischemic stroke.Front Neurol. 2022 Oct 17;13:1037663. doi: 10.3389/fneur.2022.1037663. eCollection 2022. Front Neurol. 2022. PMID: 36324389 Free PMC article.
-
Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction: Case Series and Systematic Review.Stroke. 2019 Oct;50(10):2813-2818. doi: 10.1161/STROKEAHA.119.025630. Epub 2019 Aug 22. Stroke. 2019. PMID: 31436141
-
Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?Stroke Vasc Neurol. 2016 Oct 25;1(3):115-121. doi: 10.1136/svn-2016-000033. eCollection 2016 Sep. Stroke Vasc Neurol. 2016. PMID: 28959472 Free PMC article. Review.
Cited by
-
Ischemic and Hemorrhagic Cerebrovascular Events Related to COVID-19 Coagulopathy and Hypoxemia.Int J Environ Res Public Health. 2022 Sep 19;19(18):11823. doi: 10.3390/ijerph191811823. Int J Environ Res Public Health. 2022. PMID: 36142094 Free PMC article. Review.
-
Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients.J Stroke Cerebrovasc Dis. 2023 Apr;32(4):107031. doi: 10.1016/j.jstrokecerebrovasdis.2023.107031. Epub 2023 Jan 23. J Stroke Cerebrovasc Dis. 2023. PMID: 36701854 Free PMC article.
References
-
- Zakeri A, Jadhav AP, Sullenger BA, Nimjee SM. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J Neurointerventional Surg. 2020;0:1. - PubMed
Publication types
LinkOut - more resources
Full Text Sources